Trial Profile
Atorvastatin vs. Atorvastatin/Ezetimibe in Patients With Hypo-response to Initial Dose Statin Therapy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Ezetimibe (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 05 Sep 2009 New trial record